Beibei Sun

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center · ORCID：0000-0001-9250-6882

发表论文 84 篇 · 总被引 2340 次 · h-index 29

代表论文

• Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma (2022 · Theranostics · 被引 113)
• CIP2A induces PKM2 tetramer formation and oxidative phosphorylation in non-small cell lung cancer (2024 · Cell Discovery · 被引 45)
• Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors (2022 · EBioMedicine · 被引 43)
• Nano-immunotherapy for lung cancer (2023 · Nano TransMed · 被引 33)
• Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells (2022 · Cell Discovery · 被引 33)
• MTSS1 curtails lung adenocarcinoma immune evasion by promoting AIP4-mediated PD-L1 monoubiquitination and lysosomal degradation (2023 · Cell Discovery · 被引 26)